Comparing two treatments to reduce cervical cancer risk in women with HIV
Part of Immune system & allergy, Infections clinical trials.
This study compares two treatments (Thermal Ablation and LEEP) to lower the risk of cervical cancer in women living with HIV. It aims to find which option works better and is safer for this group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between the ages of 25 and 49.
- You have tested positive for HIV.
- You are willing and able to take part in the study and give your consent.
- You are not currently pregnant and it has been at least 6 weeks since giving birth.
- You still have your cervix (you have not had a hysterectomy).
- You have never had cervical cancer or received treatment for abnormal cervical cells.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a medicine called 5-fluorouracil (5FU) after a procedure called thermal ablation helps clear HPV better than ablation alone. The study is for women with HIV in Kenya who have an HPV infection.
This study looks at whether getting the HPV vaccine along with regular cervical cancer screening (using an HPV test) can help prevent cervical cancer in women living with HIV. It is designed to be done as part of your usual HIV clinic visits, making it easier for you to take part.
This trial tests a program to screen and treat HIV-positive women for cervical cancer in La Romana, Dominican Republic. It may help catch and manage cervical cancer early.
This trial compares two ways to help women with HIV get screened for cervical cancer: a clinic-based approach versus a combined clinic and community outreach program. You may be able to provide samples yourself at a clinic or at home to test for HPV, the virus that can cause cervical cancer.
This trial compares two ways to help women living with HIV get screened for cervical cancer: one uses only clinic visits, the other adds community outreach and self-testing for HPV at home. It aims to increase screening rates and catch early signs of cervical cancer.
This study tests whether using one or two heat probes is better at removing precancerous cells from the cervix in women living with HIV. It aims to find a simpler, more effective way to prevent cervical cancer.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.